Success Metrics

Clinical Success Rate
100.0%

Based on 4 completed trials

Completion Rate
100%(4/4)
Active Trials
0(0%)
Results Posted
0%(0 trials)

Phase Distribution

Ph phase_1
2
40%
Ph not_applicable
3
60%

Phase Distribution

2

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution5 total trials
Phase 1Safety & dosage
2(40.0%)
N/ANon-phased studies
3(60.0%)

Highest Phase Reached

Phase 1

Trial Status & Enrollment

Completion Rate

80.0%

4 of 5 finished

Non-Completion Rate

20.0%

1 ended early

Currently Active

0

trials recruiting

Total Trials

5

all time

Status Distribution
Completed(4)
Terminated(1)

Detailed Status

Completed4
Withdrawn1

Development Timeline

Analytics

Development Status

Total Trials
5
Active
0
Success Rate
100.0%
Most Advanced
Phase 1

Trials by Phase

Phase 12 (40.0%)
N/A3 (60.0%)

Trials by Status

completed480%
withdrawn120%

Recent Activity

0 active trials
Showing 5 of 5
completednot_applicable

Building Resilience for Surgical Recovery

NCT06174701
completednot_applicable

Shaping Actions and Responses to Emotions

NCT04719949
withdrawnphase_1

SSIPP vs. PST vs. WLC

NCT04887350
completedphase_1

CM Delivered PST in LLD Pilot

NCT03408821
completednot_applicable

Improving Depression Treatment for Older Minority Adults

NCT00570427

Clinical Trials (5)

Showing 5 of 5 trials
NCT06174701Not Applicable

Building Resilience for Surgical Recovery

Completed
NCT04719949Not Applicable

Shaping Actions and Responses to Emotions

Completed
NCT04887350Phase 1

SSIPP vs. PST vs. WLC

Withdrawn
NCT03408821Phase 1

CM Delivered PST in LLD Pilot

Completed
NCT00570427Not Applicable

Improving Depression Treatment for Older Minority Adults

Completed

All 5 trials loaded

Drug Details

Intervention Type
BEHAVIORAL
Total Trials
5